Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference
11 Dezember 2023 - 2:00PM
Amarin Corporation plc (NASDAQ:AMRN) today announced its
participation in the 42nd Annual JP Morgan Healthcare Conference.
Amarin’s president and chief executive officer, Patrick Holt, is
scheduled to present at the conference on January 10, 2024.
42nd Annual J.P. Morgan
Healthcare Conference (January 8th-11th, 2024; San
Francisco, California)
Date/Time: January
10, 2024, 4:30 p.m. ET/ 1:30 p.m. PST
Webcast:
https://jpmorgan.metameetings.net/events/healthcare24/sessions/49593-amarin-corporation-plc/webcast?gpu_only=true&kiosk=true
The conference presentation will be webcast live
and archived on the Company’s website in the Investor Relations
section under Events and Presentations at Events | Amarin
Corporation plc.
About Amarin
Amarin is an innovative pharmaceutical company
leading a new paradigm in cardiovascular disease management. We are
committed to increasing the scientific understanding of the
cardiovascular risk that persists beyond traditional therapies and
advancing the treatment of that risk for patients worldwide. Amarin
has offices in Bridgewater, New Jersey in the United States, Dublin
in Ireland, Zug in Switzerland, and other countries in Europe as
well as commercial partners and suppliers around the world.
Availability of Other Information About
Amarin
Amarin communicates with its investors and the
public using the company website (www.amarincorp.com) and the
investor relations website (investor.amarincorp.com), including but
not limited to investor presentations and FAQs, Securities and
Exchange Commission filings, press releases, public conference
calls and webcasts. The information that Amarin posts on these
channels and websites could be deemed to be material information.
As a result, Amarin encourages investors, the media and others
interested in Amarin to review the information that is posted on
these channels, including the investor relations website, on a
regular basis. This list of channels may be updated from time to
time on Amarin’s investor relations website and may include social
media channels. The contents of Amarin’s website or these channels,
or any other website that may be accessed from its website or these
channels, shall not be deemed incorporated by reference in any
filing under the Securities Act of 1933.
Amarin Contact Information
Investor Inquiries:Investor RelationsAmarin Corporation
plcIR@amarincorp.com (investor inquiries)
Media Inquiries:CommunicationsAmarin Corporation
plcPR@amarincorp.com (media inquiries)
Amarin (NASDAQ:AMRN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024